Performance of SLDB Solid Biosciences LLC | 55% in 12m
Compare SLDB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Solid Biosciences LLC with its related Sector/Index XBI
Performance Duell SLDB vs XBI
| TimeFrame | SLDB | XBI |
|---|---|---|
| 1 Day | -2.71% | 2.02% |
| 1 Week | -5.46% | 3.93% |
| 1 Month | -3.10% | 7.25% |
| 3 Months | -1.42% | -0.71% |
| 6 Months | 255.6% | 30.27% |
| 12 Months | 55.0% | 5.80% |
| YTD | 55.0% | 2.64% |
| Rel. Perf. 1m | -0.75 | |
| Rel. Perf. 3m | 4.37 | |
| Rel. Perf. 6m | 11.75 | |
| Rel. Perf. 12m | 3.83 |
Is Solid Biosciences LLC a good stock to buy?
No, based on ValueRay Fundamental Analyses, Solid Biosciences LLC (NASDAQ:SLDB) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -63.13 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLDB as of May 2024 is 10.13. This means that SLDB is currently overvalued and has a potential downside of 4.54% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLDB as of May 2024 is 10.13. This means that SLDB is currently overvalued and has a potential downside of 4.54% (Sold with Premium).
Is SLDB a buy, sell or hold?
- Strong Buy: 5
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: SLDB is performing better - Values below 0%: SLDB is underperforming
Compare SLDB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.89% | -8.12% | 236.94% | 24.91% |
| US NASDAQ 100 | QQQ | -8.38% | -8.17% | 237.70% | 15.52% |
| US Dow Jones Industrial 30 | DIA | -7.71% | -9.03% | 240.54% | 33.10% |
| German DAX 40 | DBXD | -7.44% | -7.59% | 236.15% | 36.92% |
| UK FTSE 100 | ISFU | -8.02% | -11.21% | 238.74% | 41.05% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.98% | -6.78% | 254.73% | 66.14% |
| Hongkong Hang Seng | HSI | -11.26% | -21.43% | 254.27% | 64.92% |
| Japan Nikkei 225 | EXX7 | -5.39% | 1.11% | 243.53% | 41.47% |
| India NIFTY 50 | INDA | -6.06% | -5.19% | 239.16% | 29.19% |
| Brasil Bovespa | EWZ | -3.08% | -5.76% | 258.13% | 43.73% |
SLDB Solid Biosciences LLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.02% | -5.88% | 236.70% | 16.19% |
| Consumer Discretionary | XLY | -6.08% | -5.85% | 248.50% | 33.20% |
| Consumer Staples | XLP | -6.48% | -8.87% | 244.23% | 51.62% |
| Energy | XLE | -6.33% | -1.71% | 242.62% | 31.93% |
| Financial | XLF | -7.44% | -8.92% | 232.95% | 21.54% |
| Health Care | XLV | -8.36% | -8.56% | 240.42% | 42.43% |
| Industrial | XLI | -6.74% | -6.31% | 234.54% | 25.64% |
| Materials | XLB | -6.90% | -5.94% | 239.17% | 35.79% |
| Real Estate | XLRE | -10.21% | -9.22% | 245.91% | 46.41% |
| Technology | XLK | -9.46% | -8.81% | 238.27% | 13.93% |
| Utilities | XLU | -8.68% | -17.12% | 236.13% | 44.97% |
| Aerospace & Defense | XAR | -6.73% | -11.10% | 241.12% | 28.96% |
| Biotech | XBI | -9.39% | -10.35% | 225.33% | 49.24% |
| Homebuilder | XHB | -9.80% | -10.02% | 220.26% | -0.33% |
| Retail | XRT | -10.93% | -12.33% | 233.20% | 26.80% |
Does Solid Biosciences LLC outperform its market, is SLDB a Sector Leader?
Yes, over the last 12 months Solid Biosciences LLC (SLDB) made 55.04%, while its related Sector, the SPDR S&P Biotech (XBI) made 5.80%.
Over the last 3 months SLDB made -1.42%, while XBI made -0.71%.
Yes, over the last 12 months Solid Biosciences LLC (SLDB) made 55.04%, while its related Sector, the SPDR S&P Biotech (XBI) made 5.80%.
Over the last 3 months SLDB made -1.42%, while XBI made -0.71%.
| Period | SLDB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.10% | 7.25% | 5.02% |
| 3 Months | -1.42% | -0.71% | 5.86% |
| 12 Months | 55.04% | 5.80% | 30.13% |